Hemodynamic stability and tissue oxygenation during balanced propofol remifentanil-based anaesthesia with high level of analgesia

ISRCTN ISRCTN20153044
DOI https://doi.org/10.1186/ISRCTN20153044
Secondary identifying numbers CM-01
Submission date
19/06/2012
Registration date
13/07/2012
Last edited
17/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
On some occasions, general anesthetic with a high antinociceptive (pain-blocking) effect is required although it might cause hypotension (low blood pressure). The aim of this study is to investigate whether a high-antinociceptive general anesthetic, together with fluids and norepinephrine, results in preservation of tissue oxygen levels and cardiac (heart) output.

Who can participate?
Patients aged over 18 scheduled to receive general anesthetic for surgery that requires a high level of antinociception

What does the study involve?
General anesthetic is administered following normal clinical practice guidelines, during which tissue oxygen levels and cardiac output are measured non-invasively.

What are the possible benefits and risks of participating?
There are no benefits or risks for participants because it is an observational study and normal clinical practice guidelines are followed.

Where is the study run from?
University Medical Center Groningen (Netherlands)

When is the study starting and how long is it expected to run for?
May 2011 to July 2011

Who is funding the study?
University Medical Center Groningen (Netherlands)

Who is the main contact?
Dr Alain Kalmar

Contact information

Dr Alain Kalmar
Scientific

University Medical Center Groningen
Hanzeplein 1
PO Box 30 001
Groningen
9700RB
Netherlands

Study information

Study designSingle-center observational study
Primary study designObservational
Secondary study designOther
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleHemodynamic stability and tissue oxygenation during balanced propofol remifentanil-based anaesthesia with high level of analgesia: an observational study
Study objectivesA propofol/remifentanil based anesthesia with high stability against intermittent noxious stimuli requires a relatively low level of propofol and a relatively high level of remifentanil to preserve an adequate aneaesthesia, as described by Bouillon. This combination may induce hypotension which can be treated by fluid administration and norepinephrine. Specifically administration of norepinephrine may be controversial in the light of tissue oxygenation and stroke volume. This study investigates whether a moderate administration of norepinephrine, combined with adequate fluid therapy results in preserved cardiac output and tissue oxygenation.
Ethics approval(s)Medical Ethical Committee (METC), University Medical Center Groningen [Medisch Ethische Toetsingscommissie, Universitair Medisch Centrum Groningen], 15/04/2011, ref 2011.052
Health condition(s) or problem(s) studiedTissue oxygenation and hemodymanics in anesthesia
InterventionAdministration of norepinephrine following good clinical practice.
Intervention typeProcedure/Surgery
Primary outcome measure1. Tissue oxygenation, measured continuously and non-invasively using the InSpectra StO2 monitor (Hutchinson Technology, Hutchinson, USA)
2. Cardiac output, measured using Nexfin (BMEye, Amsterdam, Netherlands)
Secondary outcome measuresTime to extubation calculated by measuring the time interval between stopping of the syringes and the moment at which the patient is extubated
Overall study start date01/05/2011
Completion date31/07/2011

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants40
Total final enrolment40
Key inclusion criteria1. Age >18 years
2. Patients planned for ophtalmic surgery under general anesthesia
Key exclusion criteria1. Unwilling/unable to written informed consent
2. Neuropsychiatric history
Date of first enrolment01/05/2011
Date of final enrolment31/07/2011

Locations

Countries of recruitment

  • Netherlands

Study participating centre

University Medical Center Groningen
Groningen
9700RB
Netherlands

Sponsor information

University Medical Center Groningen (UMCG) (Netherlands)
Hospital/treatment centre

Hanzeplein 1
PO Box 30 001
Groningen
9700RB
Netherlands

ROR logo "ROR" https://ror.org/03cv38k47

Funders

Funder type

Hospital/treatment centre

Universitair Medisch Centrum Groningen
Government organisation / Local government
Alternative name(s)
University Medical Center Groningen, UMCG
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 30/10/2014 17/12/2020 Yes No

Editorial Notes

17/12/2020: Publication reference and total final enrolment added.
30/06/2017: Plain English summary added.